Skip to main content
. 2022 Mar 12;2022:2249834. doi: 10.1155/2022/2249834

Table 1.

Biologics in psoriasis treatment.

Name of the drug Biological target
Ustekinumab IL-12 and IL-23—p40 subunit
Guselkumab IL-23—p19 subunit
Tildrakizumab
Risankizumab
Secukinumab IL-17
Ixekizumab
Bimekizumab
Brodalumab IL-17 receptor
Etanercept TNF-α
Infliximab
Adalimumab
Certolizumab pegol
Golimumab